The price of HashiCorp Inc (NASDAQ: HCP) closed at $26.36 in the last session, down -1.61% from day before closing price of $26.79. In other words, the price has decreased by -$0.43 from its previous closing price. On the day, 1565457 shares were traded.
Ratios:
We take a closer look at HCP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.89 and its Current Ratio is at 3.38. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On February 26, 2024, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $23 to $30.
Needham reiterated its Buy rating for the stock on December 08, 2023, while the target price for the stock was revised from $36 to $27.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 11 ’24 when Holmes Marc sold 13,916 shares for $26.19 per share. The transaction valued at 364,436 led to the insider holds 0 shares of the business.
Dadgar Armon sold 35,904 shares of HCP for $913,660 on Mar 04 ’24. The CHIEF TECHNOLOGY OFFICER now owns 1,732,972 shares after completing the transaction at $25.45 per share. On Feb 26 ’24, another insider, Welihinda Navam, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 2,500 shares for $25.00 each. As a result, the insider received 62,500 and left with 62,844 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCP now has a Market Capitalization of 5.25B and an Enterprise Value of 4.01B. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.01 while its Price-to-Book (P/B) ratio in mrq is 4.33. Its current Enterprise Value per Revenue stands at 7.12 whereas that against EBITDA is -15.37.
Stock Price History:
Over the past 52 weeks, HCP has reached a high of $36.39, while it has fallen to a 52-week low of $18.91. The 50-Day Moving Average of the stock is 23.58, while the 200-Day Moving Average is calculated to be 24.81.
Shares Statistics:
According to the various share statistics, HCP traded on average about 2.61M shares per day over the past 3-months and 3.82M shares per day over the past 10 days. A total of 125.33M shares are outstanding, with a floating share count of 111.29M. Insiders hold about 44.15% of the company’s shares, while institutions hold 47.63% stake in the company. Shares short for HCP as of Feb 29, 2024 were 7.41M with a Short Ratio of 2.84, compared to 5.19M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.72% and a Short% of Float of 6.06%.
Earnings Estimates
The company has 15 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.01 for the current quarter, with a high estimate of $0.01 and a low estimate of -$0.03, while EPS last year was -$0.07. The consensus estimate for the next quarter is -$0.01, with high estimates of $0.03 and low estimates of -$0.03.
Analysts are recommending an EPS of between $0.2 and $0.01 for the fiscal current year, implying an average EPS of $0.07. EPS for the following year is $0.26, with 16 analysts recommending between $0.62 and $0.1.
Revenue Estimates
A total of 15 analysts have provided revenue estimates for HCP’s current fiscal year. The highest revenue estimate was $647.04M, while the lowest revenue estimate was $643.61M, resulting in an average revenue estimate of $645.48M. In the same quarter a year ago, actual revenue was $583.14M, up 10.70% from the average estimate. Based on 15 analysts’ estimates, the company’s revenue will be $753.15M in the next fiscal year. The high estimate is $765.39M and the low estimate is $730.7M. The average revenue growth estimate for next year is up 16.70% from the average revenue estimate for this year.
